POSTPONED – SciLifeLab COVID-19 seminars: Drug repurposing and Precision Medicine – Philip Gribbon & Päivi Östling
June 1 @ 15:15 – 16:45 CEST
This seminar is unfortunately postponed due to illness – new date not decided yet
Philip Gribbon & Päivi Östling
The fourth SciLifeLab COVID-19 seminar this spring starts with Philip Gribbon, Head of Discovery Research, Fraunhofer Institute for Translational Medicine and Pharmacology, Hamburg, Germany, talking about ” Compound repurposing in COVID-19, target and phenotypic-based approaches“.
The second talk, “Exploring the morphology of the host cell to open new possibilities in drug repurposing” will be given by Päivi Östling, Department of Oncology-Pathology, Karolinska Institutet
Moderator: Annika Jenmalm Jensen, SciLifeLab Infrastructure Director
Schedule
15:15- 16:00 | Compound repurposing in COVID-19, target and phenotypic-based approaches Philip Gribbon Fraunhofer Institute for Translational Medicine and Pharmacology, Hamburg, Germany |
16:00-16:45 | Exploring the morphology of the host cell to open new possibilities in drug repurposing Päivi Östling Department of Oncology-Pathology, Karolinska Institutet |